Yes Securities' Shivaji Thapliyal expresses optimism towards Bank of Maharashtra, DCB Bank, CSB Bank, Star Health, and CAMS, offering positive perspectives in a recent interview. For more details, check out the full interview link.

Star Health reported a significant 19.3% year-on-year increase in premium income for April, reaching ₹12.65 billion, indicating robust growth in their insurance revenue.

Investment analysts on NDTV Profit suggest offloading Star Health stocks, maintaining holdings in Bharat Forge, realizing profits from BHEL, and increasing investments in Solar Industries for strategic reasons.

Star Health experienced a notable increase of 11% in Q4 retail policies compared to the previous year, with an additional 38% growth in fresh retail policies. This surge in business resulted in a significant jump of 200% in underwriting profit, reaching Rs. 186 crore for the quarter. The full-year Gross Written Premium (GWP) also grew by 16%, amounting to Rs. 20,369 crore.

Star Health reports a significant increase in Q4 net profit to ₹1.11 billion, marking an impressive year-on-year growth compared to just ₹5 million previously. Additionally, the company's revenue for the same period reached ₹43.27 billion, representing a 14% increase over last year.

Star Health's profit after tax (PAT) for FY26 increased by 16% year-on-year to ₹911 crores, with gross written premiums also growing by the same percentage to ₹20,369 crores. The company reported an improved combined ratio of 98.8%, and holds a significant 31% market share in the retail health sector.

Star Health anticipates continued enhancement of its underwriting efficiency, despite persistent challenges facing the insurance sector.

Star Health posted impressive Q4 FY26 insurance figures, outperforming expectations, while Go Digit's results for the same period lagged behind. Canara HSBC Life also delivered strong performances during this timeframe.

Star Health intends to adjust prices for most of its operations by Q1, a decision aimed at improving profits and managing underlying business performance issues.

Star Health exhibits impressive revenue growth, strong operational performance, and a better Combined Ratio, indicating a healthier financial position. Canara HSBC Life demonstrates increased Value of New Business (VNB), margin expansion, and robust growth in the protection and annuity segments, suggesting a successful business strategy.

Star Health has announced that its Q4 and annual financial results for FY2026, accompanied by an unmodified auditor report, have been approved by the board. Key documents like audited results, regulatory disclosures, and actuarial certifications are now available on their website.

Star Health experienced a significant boost today, trading over four times its average volume of the past two weeks, resulting in a total value of Rs. 109 crores exchanged on the NSE. This surge led to an 8.3% increase in share price, setting the closing market price at Rs. 560.

Star Health aims for substantial revenue growth in the high teen range, as well as a return on equity (RoE) within the mid to high teen percentages, based on the latest conference call announcement.

Star Health reported a significant increase in Q4 net profit, reaching ₹111.3 crore compared to just ₹0.5 million the previous year. The growth was supported by a narrowing of underwriting losses and an elevated 14% rise in premiums. Shares closed at ₹516.35 on NSE, marking a 0.15% increase, while net earned premium expanded by 13.9% to ₹4,327.2 crore.

Star Health has received approval from both the BSE and NSE to reclassify two entities as public, moving them out of promoter control. The company is now focused on ensuring compliance with listing regulations for these entities.

Star Health reported a significant 16% increase in monthly premiums for March, reaching INR 25.67 billion compared to the previous year. This growth suggests a steady expansion of their health insurance business.

The insurance regulator IRDAI has given the green light for the transfer of 8.29 crore shares owned by the late Rakesh Jhunjhunwala in Star Health. This transfer will take place following a probate process, and it complies with disclosure requirements under SEBI regulations.

Star Health maintains a strong credit standing, as Care Ratings has confirmed the AA 'Stable' rating for both its issuer and subordinate debt. More information about this disclosure, which adheres to SEBI regulations, can be found on Star Health's official website.